Skip to content
Search

Latest Stories

'Closely examine the worrying mix of challenges community pharmacies face', CCA urges Darzi Review

'Closely examine the worrying mix of challenges community pharmacies face', CCA urges Darzi Review

The CCA figures show that at the current growth rate, it would take 88 years to meet the NHS Long-Term Workforce Plan’s goals for the pharmacy workforce

A call to action has been issued by the Company Chemists’ Association (CCA) in its submission to the Darzi Review, highlighting the critical need for recognition and revitalization of the community pharmacy sector.

The CCA warns that chronic underfunding and a flawed Community Pharmacy Contractual Framework (CPCF) have resulted in a reduction of over 1,200 pharmacies since 2015.


This reduction, coupled with increasing workforce pressures, is exacerbating health inequalities, particularly in deprived communities.

The CCA’s submission stresses that the government must address these longstanding funding issues to fully unlock the potential of community pharmacies in addressing the nation's health challenges.

The report argues that while initiatives like Pharmacy First have been positive, they only scratch the surface of the sector’s capabilities.

A key focus of the submission is the need for Independent Prescribing to alleviate the burden on other NHS services, especially general practice.

The CCA contends that with proper NHS commissioning and support, Independent Prescribing could significantly reduce pressure on GPs and enhance patient care.

However, the current NHS England plans are seen as insufficient to capitalize on this opportunity.

The CCA's submission outlines several critical concerns including static core funding, inadequate retained margins and workforce shortages.

According to CCA, despite an 8 per cent increase in dispensing volumes since 2015/16, core funding for pharmacies has remained unchanged.

This stagnation has contributed to the closure of nearly 500 pharmacies in the past year alone, with the impact most severe in economically disadvantaged areas.

The current funding model has failed to keep pace with rising costs and inflation, leading to medicine shortages and increased prices for taxpayers.

Moreover, the most deprived communities are disproportionately affected by reduced pharmaceutical services, further widening health inequalities.

As per the statistical figures, the CCA has highlighted that at the current growth rate, it would take 88 years to meet the NHS Long-Term Workforce Plan’s goals for the pharmacy workforce.

Dr. Nick Thayer, Head of Policy at the CCA, emphasised the urgent need for reform: “Community pharmacy is operating under severe constraints due to historic underfunding and workforce challenges.

"Despite these pressures, pharmacies are expected to manage increasing NHS prescriptions and services.

"It is imperative that the Darzi Review thoroughly examines these issues.”

Dr. Thayer added that with appropriate funding and a revamped CPCF, community pharmacies could help free up 42 million GP appointments annually through services like Independent Prescribing, cardiovascular disease screening, and vaccinations.

He urged the government to consider the CCA’s evidence and act decisively to harness the full potential of the community pharmacy sector.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less